VTB Bank will provide the Federal state unitary enterprise “Saint-Petersburg research Institute of vaccines and sera and enterprise and Biopharmaceutical Plant under Federal Medical Biological Agency of Russia” a loan totalling more than $ 12 500 000 for a period of 5 years. The loan agreement was signed in the framework of previously established credit limit for
March 13, with the support of Industrial Policy and Innovations Committee of St. Petersburg was held the German-Russian Seminar on public health. Delegates from both countries discussed the interaction between Federal Land Mecklenburg-Western Pomerania and Saint Petersburg in the sphere of public health. Germany is one of the main trading partners for St. Petersburg, and
During the visit of Minister of Health of Cuba was acquainted.with the potential of the institute for the transfer of technology.and visited the production site of influenza vaccine. Dr. Roberto Morales Ojeda Minister of Health of Cuba, Dra. Mayda Mauri Perez vice-president of BioCubaFarma, Dra. Idania Caballero representative of BioCubaFarma in Russia and Emilio Lozada
Tagged under: , , ,

Our team at the WorldSkills (Business today)

Tagged under: ,

SPbSRIVS team at the championship WorldSkills

Participants of the competition are laboratory assistants of SPbSRIVS. Within three competitive days, they need to complete several tasks. Among them, calibration of dishes, standardization of solutions, determination of the total hardness, as well as determination of vanadium concentration in water. As experts say – this is a very important stage. Vanadium is a heavy
Tagged under: ,

20 million doses

SPbSRIVS has completed delivery of preventive flu vaccines under a government contract as part of the National Immunization Calendar, reported Mr. Stanislav Petrovsky, First Deputy Director at SPbSRIVS: “This year, SPbSRIVS was the the first one to timely complete delivery of more than 9 million doses of the influenza vaccine under a government contract and
Tagged under: ,
In 2016, SPbSRIVS produced 20 million doses of influenza vaccine, which is 12 million doses more than last year. Over the past three years, the combined output growth has been more than threefold. “In 2016, SPbSRIVS produced almost half of the total number of influenza vaccines required for the National Immunization Calendar. This makes us

SPbSRIVS supports applied research

The project “Development of an encapsulation and immobilization technology for multipotent mesenchymal stromal cells and of an inhalation targeted delivery method in the treatment for severe upper respiratory burns” by the Mendeleyev Russian Chemistry and Technology University will be given support by SPbSRIVS. The project has been submitted to the grant contest held as part